- Home
- HBAN vs WAT Comparison
HBAN vs WAT Comparison
Compare HBAN & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBAN
- WAT
- Stock Information
- Founded
- HBAN 1866
- WAT 1958
- Country
- HBAN United States
- WAT United States
- Employees
- HBAN N/A
- WAT N/A
- Industry
- HBAN Major Banks
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- HBAN Finance
- WAT Industrials
- Exchange
- HBAN Nasdaq
- WAT Nasdaq
- Market Cap
- HBAN 25.6B
- WAT 20.8B
- IPO Year
- HBAN N/A
- WAT 1995
- Fundamental
- Price
- HBAN $16.71
- WAT $287.51
- Analyst Decision
- HBAN Buy
- WAT Hold
- Analyst Count
- HBAN 20
- WAT 15
- Target Price
- HBAN $18.32
- WAT $377.80
- AVG Volume (30 Days)
- HBAN 34.1M
- WAT 819.4K
- Earning Date
- HBAN 07-18-2025
- WAT 08-04-2025
- Dividend Yield
- HBAN 3.71%
- WAT N/A
- EPS Growth
- HBAN 26.38
- WAT 8.23
- EPS
- HBAN 1.34
- WAT 11.02
- Revenue
- HBAN $7,237,000,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- HBAN $17.45
- WAT $6.11
- Revenue Next Year
- HBAN $5.28
- WAT $6.44
- P/E Ratio
- HBAN $12.48
- WAT $26.09
- Revenue Growth
- HBAN 7.84
- WAT 2.57
- 52 Week Low
- HBAN $11.92
- WAT $284.65
- 52 Week High
- HBAN $18.45
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- HBAN 50.74
- WAT 26.11
- Support Level
- HBAN $16.38
- WAT $284.65
- Resistance Level
- HBAN $17.65
- WAT $360.00
- Average True Range (ATR)
- HBAN 0.38
- WAT 12.24
- MACD
- HBAN -0.10
- WAT -7.05
- Stochastic Oscillator
- HBAN 25.18
- WAT 3.49
About HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with around $200 billion in assets (as of 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.